Play stunning VR adventure game The Assembly at EGX

EGX, the UK’s largest games event, and nDreams, the UK’s biggest specialist VR developer-publisher, are excited to announce that nDreams’ immersive virtual reality game The Assembly will be playable publically for the first time at EGX this 24th-27th September. The Assembly is an incredibly immersive story-driven, character-focussed first-person adventure game built from the ground-up for

Mercia launches dedicated EIS/SEIS fund for commercialising university spinouts

Leading technology investor Mercia Fund Management (“Mercia”) has launched its sixth EIS and SEIS hybrid fund, which is purely focused on seeking investments originating from its extensive university partnerships across the Midlands, the North and Scotland, where it sees strong opportunities across key technology led sectors in which it holds deep expertise. The University Growth

Commercialising university IP (tax) efficiently

Since Gordon Brown first proposed in 2006 that universities should prove their economic contribution in order to secure funding, the spinout sector has steadily grown into a varied and exciting territory for IP-rich technology businesses. And with good reason: the UK boasts some of the finest academic institutions in the world, with a cohort of

Leicester spinout MIP Diagnostics appoints CEO

MIP Diagnostics, a University of Leicester spinout that develops molecularly imprinted polymers for research purposes, diagnostics and drug discovery, has begun the initial expansion of its business operations with the appointment of Adrian Kinkaid as CEO. This follows a recent investment of £182,000 made by Mercia Fund Management. Adrian will begin driving the technology into

Investment support for technology-backed or knowledge-intensive businesses

The Enterprise Investment Scheme (EIS) and Seed EIS vehicles provide a legitimate government-introduced, tax- free capital growth environment for investments held for at least three years. Private investors can also expect a 30-50% income tax rebate on funds invested, alongside additional tax advantages including loss relief. Such tax advantages have proven very successful in encouraging

The Native Antigen Company launches new e-commerce platform for underserved antigen sector

Following the recent appointment of Steve Powell as CEO and in response to the current underprovision of pure antigens for researchers in vaccine development, diagnostics and academia, The Native Antigen Company (NAC) has developed a convenient e-commerce platform that will facilitate access to its high quality catalogue of native and recombinant antigens. NAC, divested from

NuVision becomes first University of Nottingham spinout to receive seed funding from Mercia

Mercia Fund Management (MFM), a national fund management business with a focus on the Midlands, North and Scotland, has committed £379,000 in seed funding to NuVision Biotherapies Ltd, a University of Nottingham spinout developing effective and affordable eye care medical solutions for humans and animals. The funding will support the commercialisation of NuVision’s ground-breaking product,

The Mercia Group Quarterly: Ambition

Our theme over the next period is AMBITION, both for Mercia and our innovative portfolio of technology companies, as we seek to accelerate their growth whilst scaling our own investment model. Ambition is also a key attribute that we look for in the entrepreneurs we back and support, with a recent interview with Crowd Reactive

Finalists announced for inaugural Growth Investor Awards

The most innovative and impactful fund managers, investment platforms, financial advisers and wealth managers specialising in alternative investments have today been revealed as finalists for the inaugural Growth Investor Awards – which recognise all those involved in putting investment to work in UK SMEs and enabling ‘scale up’ businesses to realise their full potential to